NEI
CAI

Northwest & Ethical Investments’s Caris Life Sciences CAI Stock Holding History

Northwest & Ethical Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
12,500
+1,900
+18% +$41.5K 0.01% 473
2025
Q4 		$290K Buy
+10,600
New +$299K 0.01% 450

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Northwest & Ethical Investments's CAI Position: Q1 2026 in Review

Northwest & Ethical Investments increased its Caris Life Sciences (CAI) stake by 18% in Q1 2026, buying an estimated $41.5K and bringing the position to 12,500 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #473.

Northwest & Ethical Investments first reported a position in CAI in Q4 2025 and has held it in 2 quarters since. The position peaked at $290K in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Northwest & Ethical Investments held 12,500 shares of Caris Life Sciences worth $238K as of Q1 2026.
  • Northwest & Ethical Investments bought 1,900 Caris Life Sciences shares in Q1 2026, an estimated $41.5K.
  • Caris Life Sciences made up 0.01% of Northwest & Ethical Investments's portfolio in Q1 2026, its #473 holding.
  • Northwest & Ethical Investments first reported a position in Caris Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Northwest & Ethical Investments's Caris Life Sciences position peaked at $290K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.